Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Tetramethylammonium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.39 |
| ▸ | BBOX1 | O75936 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | NT5E | P21589 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetramethylammonium Ion SCHEMBL8460208 | 0.96 | TSHR (0.57) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Tetramethylammonium Ion SCHEMBL28051064 | 0.96 | TSHR (0.57) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Tetramethylammonium Ion SCHEMBL3909246 | 0.96 | TSHR (0.57) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Tetramethylammonium Ion SCHEMBL15348713 | 0.93 | MEN1 (0.53) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Tetramethylammonium Ion SCHEMBL28468866 | 0.89 | TSHR (0.50) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL11797353 | 0.85 | TSHR (0.53) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL28398774 | 0.82 | TSHR (0.73) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Tetramethylammonium Ion SCHEMBL36961 | 0.82 | CHRNB2 (0.40) | TSHRMEN1ALDH1A1KMT2ABBOX1 | |
| Tetramethylammonium Ion SCHEMBL2910816 | 0.82 | CA5A (0.60) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Tetramethylammonium Ion SCHEMBL27867088 | 0.82 | CA5A (0.60) | TSHRMEN1ALDH1A1KMT2ACA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079810-A | Aromatic diamine and polyimide containing amido, preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-117143592-B | Mn (Mn)4+Activated fluoride (oxide) red fluorescent material and preparation method thereof | 华南理工大学 | 2026-05-22 | — | — | CN | claimed |
| CN-116627004-B | Preparation method of water-based developing solution, water-based developing solution and application thereof | 江西萨瑞微电子技术有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4705547-A1 | PROCESS FOR THE PREPARATION OF 1,1,4,4-TETRAALKYLOXY-2-BUTENE | DSM IP Assets B.V. (NL) | 2026-03-11 | — | — | EP | claimed |
| US-20260015560-A1 | COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES | ENTEGRIS INC (US) | 2026-01-15 | — | — | US | claimed |
| US-20250353823-A1 | PROCESS FOR THE PREPARATION OF ALKOXYLATED 2,5-DIHYDROFURAN | DSM IP ASSETS BV (NL) | 2025-11-20 | — | — | US | claimed |
| US-20250171494-A1 | METHOD FOR SYNTHESIZING PEPTIDE CONTAINING N-SUBSTITUTED AMINO ACID | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-05-29 | — | — | US | claimed |
| US-20250171409-A1 | PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES | ADAMA MAKHTESHIM LTD. (IL) | 2025-05-29 | — | — | US | claimed |
| CN-120005391-A | High-light-transmittance nylon composite material and preparation method thereof | 浙江俪盛新材料有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-119876971-A | Acidic CO2Electrolytic process | 南京大学 | 2025-04-25 | — | — | CN | claimed |
| EP-0414506-A1 | Toner and developer compositions with charge enhancing additives | XEROX CORPORATION (US) | 1991-02-27 | — | — | EP | claimed |
| EP-0414502-A1 | Toner composition | XEROX CORPORATION (US) | 1991-02-27 | — | — | EP | claimed |
| US-4937157-A | Toner and developer compositions with charge enhancing additives | XEROX CORPORATION (US) | 1990-06-26 | — | — | US | claimed |
| US-4904762-A | Toner compositions with charge enhancing additives | XEROX CORPORATION (US) | 1990-02-27 | — | — | US | claimed |
| US-4665028-A | WATER SOLUBLE SALT TO H INDER ENZYME SOLUBILITY | NOVO INDUSTRI A/S (DK) | 1987-05-12 | — | — | US | claimed |
| EP-0049577-B1 | ALPHA-CYANOPHENOXYBENZYLAMINE DERIVATIVES, PROCESSES FOR PREPARING THEM, AND THEIR USE AS INTERMEDIATES FOR THE PREPARATION OF PYRETHROID INSECTICIDES | ICI AUSTRALIA LIMITED (AU) | 1984-04-11 | — | — | EP | claimed |
| US-4400567-A | WITH A PEROXYDISULFATE IN THE PRESENCE OF A QUATERNARY AMMONIUM COMPOUND | EXXON RESEARCH & ENGINEERING CO. (US) | 1983-08-23 | — | — | US | claimed |
| EP-0075494-A1 | Oxidative coupling of aromatic methyl groups | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1983-03-30 | — | — | EP | claimed |
| US-4322271-A | ETHERIFICATION OF AN N-ETHYL AMIDE BY ANODIZING WITH AN ALCOHOL; ALKYLATION; DEETHERIFICATION | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-03-30 | — | — | US | claimed |
| US-3996078-A | ALKANOLAMINE NITRATE OR PERCHLORATE | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) | 1976-12-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250353823-A1 | PROCESS FOR THE PREPARATION OF ALKOXYLATED 2,5-DIHYDROFURAN | CYP4F2, CYP4F12, CYP2F1 | TSHR 4858/4885MEN1 4538/4885ALDH1A1 59/4885 |
| US-20250171494-A1 | METHOD FOR SYNTHESIZING PEPTIDE CONTAINING N-SUBSTITUTED AMINO ACID | NPPA, VIP, DNPEP | TSHR 1832/4885MEN1 1155/4885ALDH1A1 4281/4885 |
| US-20250171409-A1 | PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES | DDT, IDO2, INSR | TSHR 407/4885MEN1 3057/4885ALDH1A1 1545/4885 |
| US-20260015560-A1 | COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES | TET2, ASIC1, PIEZO1 | TSHR 2647/4885MEN1 2976/4885ALDH1A1 789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.